Skip to main content

Developing safer treatments for ischaemic stroke

7th August, 2022

HRI has launched an international drug discovery project investigating the development of a photo-responsive therapy for ischaemic stroke.

Read more

Distinguished Professor Annemarie Hennessy AM celebrates 20 years at HRI

28th July, 2022

Distinguished Professor Annemarie Hennessy AM is celebrating 20 years at HRI as Vascular Immunology Group Leader this year.

Read more

HRI welcomes new Scientific Director, Prof Andrew Coats AO

27th July, 2022

HRI is delighted to announce that world-leading cardiovascular expert Professor Andrew Coats AO is joining the Institute as Scientific Director.

Read more

Advancing medical treatment for diabetes patients - some more likely to develop atherosclerosis

18th July, 2022

HRI's Dr Ashish Misra has received a 2022 Diabetes Australia research grant for his project to identify the mechanisms linking diabetes with atherosclerosis.

Read more

Launching the CHAANZ Congenital Heart Disease Registry

1st July, 2022

HRI is establishing the Congenital Heart Alliance of Australia and New Zealand (CHAANZ) Congenital Heart Disease Registry, a comprehensive NZ registry of demographic and clinical data from cohorts of paediatric and adult cases of CHD from sites across New Zealand.

Read more

Dr Yen Chin Koay wins ISHR International Poster Prize

22nd June, 2022

Dr Yen Chin Koay of HRI’s Cardiometabolic Disease Group was awarded the International Poster Prize at the XXIV World Congress International Society for Heart Research (ISHR) 2022, Berlin, Germany.

Read more

The Congenital Heart Fitness Intervention Trial bringing hope

15th June, 2022

HRI is embarking on “CH-FIT: The Congenital Heart Fitness Intervention Trial” to investigate the benefits of exercise for people with congenital heart disease.

Read more

Sepsis research accelerated by James N. Kirby Foundation Grant

14th June, 2022

Dr Christopher Stanley’s research focuses on cardiovascular decline seen in sepsis, also known as septic shock – for which there is no clinical treatment.

Read more

Is myeloperoxidase the key to preventing heart attack and stroke?

27th May, 2022

Dr James Nadel has published a literature review in Cardiovascular Research which explores the role of myeloperoxidase (MPO) in cardiovascular disease.

Read more


Every donation to the Heart Research Institute is an investment into the lives of millions.

Help us to make a long-lasting difference by donating now.

Other ways you can help